GlassScriptPhysician profile
Meghan Cirulis
NPI 1649690744
$18,100.65
in general payments reported to CMS, 2019-2025
7 companies · $17K in 2025
The $17K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $64.29 · 2024: $954 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $2,967 · Food and Beverage: $2,069 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,910.00 |
| Travel and Lodging | $2,966.83 |
| Food and Beverage | $2,068.84 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $8,426.53 | 2023-2025 | Tyvaso |
| Merck Sharp & Dohme LLC | $7,972.56 | 2024-2025 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $1,308.13 | 2024-2025 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $220.71 | 2024 | |
| Insmed, INC. | $97.42 | 2025 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $45.36 | 2024-2025 | Tezspire, Airsupra |
| Janssen Pharmaceuticals, INC | $29.94 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Cirulis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.